Mark Redston

18.8k total citations · 4 hit papers
114 papers, 12.4k citations indexed

About

Mark Redston is a scholar working on Oncology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Mark Redston has authored 114 papers receiving a total of 12.4k indexed citations (citations by other indexed papers that have themselves been cited), including 65 papers in Oncology, 59 papers in Pathology and Forensic Medicine and 39 papers in Surgery. Recurrent topics in Mark Redston's work include Genetic factors in colorectal cancer (56 papers), Cancer Genomics and Diagnostics (26 papers) and Colorectal Cancer Treatments and Studies (25 papers). Mark Redston is often cited by papers focused on Genetic factors in colorectal cancer (56 papers), Cancer Genomics and Diagnostics (26 papers) and Colorectal Cancer Treatments and Studies (25 papers). Mark Redston collaborates with scholars based in United States, Canada and United Kingdom. Mark Redston's co-authors include Steven Gallinger, Robert Gryfe, Carlos Caldas, Ralph H. Hruban, Richard M. Goldberg, Albert Seymour, Hyeja Kim, Bharati Bapat, Eric J. Holowaty and Melyssa Aronson and has published in prestigious journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

Mark Redston

112 papers receiving 12.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor Microsatellite-Instability Status as a Predictor of Benefit from Fluorouracil-Based Adjuvant Chemotherapy for Colon Cancer

2003 1.6k citations Daniel J. Sargent, Stephen N. Thibodeau et al. New England Journal of Medicine profile →
Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal Cancer

2000 1.1k citations Hyeja Kim, Eugene Hsieh et al. New England Journal of Medicine profile →
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma

1994 912 citations Mark Redston, Ralph H. Hruban et al. profile →
Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma

2003 765 citations Mark Redston, Ronald A. DePinho et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mark Redston United States	52	8.2k	5.7k	4.1k	3.3k	2.5k	114	12.4k
Jeremy R. Jass Australia	77	13.4k 1.6×	12.4k 2.2×	4.1k 1.0×	4.0k 1.2×	4.9k 2.0×	229	20.0k
Teresa A. Brentnall United States	51	4.1k 0.5×	1.9k 0.3×	3.0k 0.7×	1.9k 0.6×	2.0k 0.8×	119	8.5k
G.J.A. Offerhaus Netherlands	46	5.0k 0.6×	1.9k 0.3×	2.4k 0.6×	1.8k 0.5×	2.9k 1.2×	100	8.1k
Barry Iacopetta Australia	50	5.2k 0.6×	3.4k 0.6×	3.1k 0.8×	1.9k 0.6×	1.1k 0.5×	132	9.0k
Hans Morreau Netherlands	52	4.0k 0.5×	3.4k 0.6×	2.5k 0.6×	2.4k 0.7×	1.2k 0.5×	207	8.3k
Manuel Sobrinho‐Simões Portugal	65	3.6k 0.4×	3.1k 0.5×	5.0k 1.2×	1.5k 0.5×	4.4k 1.8×	357	14.9k
Christophe Rosty Australia	42	4.4k 0.5×	2.3k 0.4×	2.7k 0.6×	1.6k 0.5×	1.3k 0.5×	134	7.2k
Matthias Kloor Germany	51	5.8k 0.7×	3.8k 0.7×	2.5k 0.6×	2.7k 0.8×	1.3k 0.5×	176	9.4k
Siu Tsan Yuen Hong Kong	45	3.1k 0.4×	2.3k 0.4×	4.3k 1.0×	2.8k 0.8×	2.2k 0.9×	94	9.1k
Mingzhao Xing United States	58	4.0k 0.5×	1.5k 0.3×	6.2k 1.5×	1.5k 0.5×	1.5k 0.6×	120	13.9k

Countries citing papers authored by Mark Redston

Since Specialization

Citations

This map shows the geographic impact of Mark Redston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Redston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Redston more than expected).

Fields of papers citing papers by Mark Redston

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Redston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Redston. The network helps show where Mark Redston may publish in the future.

Co-authorship network of co-authors of Mark Redston

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Redston. A scholar is included among the top collaborators of Mark Redston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Redston. Mark Redston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhang, Xuchen, Huaibin M. Ko, Stephen M. Lagana, et al.. (2024). Esophageal squamous cell carcinoma with pagetoid spread: a clinicopathologic study. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 486(2). 313–322.

Redston, Mark, et al.. (2023). Ang1 and Ang4 differentially affect colitis and carcinogenesis in an AOM-DSS mouse model. PLoS ONE. 18(3). e0281529–e0281529. 1 indexed citations

Jessup, Chad, et al.. (2015). Importance of universal mismatch repair protein immunohistochemistry in patients with sebaceous neoplasia as an initial screening tool for Muir-Torre syndrome. Human Pathology. 49. 1–9. 38 indexed citations

Cho, Nancy L., et al.. (2010). Immunohistochemical and Molecular Analysis of Tyrosine Kinase Activity in Desmoid Tumors. Journal of Surgical Research. 173(2). 320–326. 9 indexed citations

Bertagnolli, Monica M., Robert S. Warren, Donna Niedzwiecki, et al.. (2009). p27Kip1 in Stage III Colon Cancer: Implications for Outcome following Adjuvant Chemotherapy in Cancer and Leukemia Group B Protocol 89803. Clinical Cancer Research. 15(6). 2116–2122. 14 indexed citations

Cho, Nancy L., Mark Redston, Ann G. Zauber, et al.. (2008). Aberrant Crypt Foci in the Adenoma Prevention with Celecoxib Trial. Cancer Prevention Research. 1(1). 21–31. 46 indexed citations

Martin, Eric S., Giovanni Tonon, Raktim Sinha, et al.. (2007). Common and Distinct Genomic Events in Sporadic Colorectal Cancer and Diverse Cancer Types. Cancer Research. 67(22). 10736–10743. 54 indexed citations

Cho, Nancy L., Mark Redston, Adelaide M. Carothers, et al.. (2006). Predictive role of aberrant crypt foci (ACF) as surrogate endpoint biomarkers of colorectal cancer.. Cancer Epidemiology and Prevention Biomarkers. 15. 1 indexed citations

Haskell, Henry, Harley A. Haynes, Phillip H. McKee, et al.. (2005). Basal cell carcinoma with matrical differentiation: a case study with analysis of β‐catenin*. Journal of Cutaneous Pathology. 32(3). 245–250. 25 indexed citations

10.

Bacani, Julinor, Nando Di Nicola, K. G. Mitchell, et al.. (2005). Tumor Microsatellite Instability in Early Onset Gastric Cancer. Journal of Molecular Diagnostics. 7(4). 465–477. 58 indexed citations

11.

Moran, Amy E., Adelaide M. Carothers, Michael J. Weyant, Mark Redston, & Monica M. Bertagnolli. (2005). Carnosol inhibits beta-catenin tyrosine phosphorylation and prevents adenoma formation in the C57BL/6J/Min/+ (Min/+) mouse.. PubMed. 65(3). 1097–104. 69 indexed citations

12.

Lindor, Noralane M., Lawrence J. Burgart, Olga Leontovich, et al.. (2002). Immunohistochemistry Versus Microsatellite Instability Testing in Phenotyping Colorectal Tumors. Journal of Clinical Oncology. 20(4). 1043–1048. 455 indexed citations

13.

Brubaker, Patricia L., Daniel J. Drucker, L. Sylvia, et al.. (2002). Prolonged Gastrointestinal Transit in a Patient with a Glucagon-Like Peptide (GLP)-1- and -2-Producing Neuroendocrine Tumor. The Journal of Clinical Endocrinology & Metabolism. 87(7). 3078–3083. 28 indexed citations

14.

Haider, Masoom A., Marianne Michal Amitai, Daniel Rappaport, et al.. (2002). Multi–Detector Row Helical CT in Preoperative Assessment of Small (≤1.5 cm) Liver Metastases: Is Thinner Collimation Better?. Radiology. 225(1). 137–142. 91 indexed citations

15.

Thompson‐Fawcett, Mark, Zane Cohen, Robin S. McLeod, Victoria Marcus, & Mark Redston. (2001). Risk of dysplasia in long-term ileal pouches and pouches with chronic pouchitis. Gastroenterology. 121(2). 275–281. 69 indexed citations

16.

Lal, Geeta, Geoffrey Liu, Pardeep Kaurah, et al.. (2000). Inherited predisposition to pancreatic adenocarcinoma: role of family history and germ-line p16, BRCA1, and BRCA2 mutations.. PubMed. 60(2). 409–16. 184 indexed citations

17.

Kim, Hyeja, Eugene Hsieh, Melyssa Aronson, et al.. (2000). Tumor Microsatellite Instability and Clinical Outcome in Young Patients with Colorectal Cancer. New England Journal of Medicine. 342(2). 69–77. 1066 indexed citations breakdown →

18.

Pal, Tuya, Lisa Madlensky, Christopher Sherman, et al.. (1999). Mismatch Repair Gene Defects Contribute to the Genetic Basis of Double Primary Cancers of the Colorectum and Endometrium. Human Molecular Genetics. 8(5). 823–829. 69 indexed citations

19.

Madlensky, Lisa, Bharati Bapat, Mark Redston, et al.. (1997). Using genetic information to make surgical decisions. Diseases of the Colon & Rectum. 40(2). 240–243. 5 indexed citations

20.

DiGiuseppe, Joseph A., Mark Redston, Charles J. Yeo, S E Kern, & Ralph H. Hruban. (1995). p53-independent expression of the cyclin-dependent kinase inhibitor p21 in pancreatic carcinoma.. PubMed. 147(4). 884–8. 118 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact